Skip to main content
  • Textbook
  • © 2011

Incentives for Research, Development, and Innovation in Pharmaceuticals

  • In-depth discussion of neglected health economics issues
  • Includes up to date analysis of new data
  • Written by a collection of the leading minds in the field
  • Ground breaking ideas to enhance research and development in the pharmaceutical industry

Part of the book series: Series economia de la salud y gestion sanitaria (SESGS)

Buy it now

Buying options

eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (7 chapters)

  1. Front Matter

    Pages I-IX
  2. Introduction

    • Walter García-Fontes
    Pages 1-4
  3. Incentives to innovate: A survey

    • Walter García-Fontes
    Pages 5-14
  4. The use of pay-for-performance for drugs: Can it improve incentives for innovation?

    • Adrian Towse, Louis Garrison, Ruth Puig-Peiró
    Pages 69-80

About this book

Incentives for innovation are particularly relevant in the pharmaceutical industry where not all social needs provide equally profitable opportunities and where most OECD countries try to implement different measures that promote research in these less profitable areas. This book describes how incentives can be provided to deal with less profitable activities when no clear markets exist for the innovations. The book discusses alternative mechanisms to substitute for inexistent markets, situations where traditional instruments have proven totally insufficient, and the clear mismatch between the size of the markets being targeted and the incentives being provided. Patents become an ineffective way to incentivise R&D when the appropriability is low; this book provides alternative ideas such as allowing for a period of data exclusivity to firms that develop new drugs.

Authors and Affiliations

  • Departamento de Economía y Empresa, Universidad Pompeu Fabra, Barcelona, Spain

    Walter García-Fontes

About the author

Walter Garcia-Fontes is an associate professor at the Department of Economics and Business of Universitat Pompeu Fabra. His research interests are in Industrial Organization, firm innovation, technological change and applied econometrics. He has published his work in leading international field journals. He has coordinated various projects in the European Commission Framework Programmes studying the European chemical industry and the organizational changes related to new industrial relations.

Bibliographic Information

Buy it now

Buying options

eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access